Skip to main content
. 2021 Nov 12;11:796839. doi: 10.3389/fonc.2021.796839

Table 2.

HIF-1α expression and clinical outcome of Sorafenib treatment.

HIF-1α mRNA expression p
High (n = 26) Low (n = 26)
TTP 8.0 12.0 0.005
6.9–9.1 (M) 10.9–13.1 (M)
OS 10.0 14.0 0.032
6.8–13.2 (M) 8.8–19.1 (M)

TTP, time to progress; OS, overall survival; M, months.